EmpiricalHow Solo Dermatologists Can Use AI · A Three-Tier Practical Framework

AI Adoption Among Israeli Dermatologists

A Preliminary Cross-Sectional Survey Revealing the Privacy Paradox
Asaf Givon¹ · Prof. Baruch Kaplan MD⁵ · Yehonatan Kaplan MD²,³,⁴
¹ Gray School of Medicine, Tel Aviv University · ² Maccabi Healthcare Services · ³ Assuta Medical Center · ⁴ Herzliya Medical Center · ⁵ Adelson School of Medicine, Ariel University · dr@kaplanderm.com
Empirical Anchor for the Trilogy

Israeli dermatologists are among the world's most enthusiastic AI users, and among the least equipped to use it clinically. The gap is not motivational; it is infrastructural. This survey (N=30) provides the empirical motivation for the Tier 1, Tier 2, and Tier 3 reviews: the enthusiasm is already there; the bridge to compliant clinical practice is missing.

Figure 1 · Survey Dashboard · N=30 Israeli Dermatologists, March 2026

Survey Dashboard · Givon et al. 2026

📋 STROBE-compliant ⚠ Privacy Paradox
⚠ The Privacy Paradox Main Finding
93%
Use AI weekly
n = 28 of 30
73%
Enter patient clinical info
n = 22 of 30
73%
Unaware BAA platforms exist
n = 22 of 30
3%
Use BAA-covered platform
n = 1 of 30
63%
Enter PHI without awareness
of compliant alternatives
📊 Cohort & Coverage
N=30
Total respondents
~8%
Of ~400 active Israeli derm
97%
Early-career (≤10 y)
19
Item Hebrew questionnaire
Recruitment: Anonymous online survey, March 2026.
Ethics: Maccabi REC exemption.
Coverage: healthcare AI adoption in Israel lags every other major sector (~8.3% vs 35-50% in finance, education, marketing).
⭐ Trust Hierarchy Median 1-5 Likert
Drug interactions
5
Pathology summary
3
Treatment planning
2
Image differential
1
Dermoscopy
1
Trust inversely correlates with diagnostic visual complexity: highest for text reasoning, lowest for image interpretation.
🚧 Barriers & Facilitators
Top barriers
Accuracy concerns
67%
Lack of training
60%
Privacy concerns
50%
Cost
33%
Top facilitators
Derm-specific tools
73%
CME training
70%
Institutional governance
53%

Background & Methods

Israel ranks first globally in per-capita AI usage (4.9 to 7.0 times the global average), yet healthcare AI adoption lags every other industry. To our knowledge, no published data describe AI usage among Israeli dermatologists.

Anonymous cross-sectional online survey (March 2026), 19-item Hebrew questionnaire covering demographics, AI usage, privacy practices, training, trust across five clinical scenarios, and barriers. STROBE-compliant.

Headline Findings

  • 93% use AI weekly; 73% enter patient clinical information
  • 73% are unaware that BAA-covered platforms exist; only 3% use one
  • 63% net: enter PHI without awareness of compliant alternatives
  • Trust is highest for drug-interaction queries, lowest for dermoscopy

Healthcare vs Other Sectors · Israeli AI Use

SectorAI Adoption
Healthcare (this survey)~8.3%
Finance~50%
Marketing~45%
Education~40%
Manufacturing~35%
Retail~30%

Conclusions & Implications

Even among early-career Israeli dermatologists predisposed to technology adoption, clinical AI integration remains constrained and frequently non-compliant. The gap is infrastructural, not motivational.

Closing it requires CME programmes, dermatology-specific tools, institutional governance, and awareness campaigns on existing BAA-covered platforms.

The enthusiasm is already there. What is missing is the bridge between personal adoption and clinical practice.